Stramsen Biotech Inc. Announced Military Veteran Mr. Chris White -(MBA) as The New President and Chief Financial Officer

Posted on by

Stramsen’s pipeline has 32 drug candidates. Multiple FDA – IND applications are expected to be filed soon. HOUSTON, Aug. 29, 2023 /PRNewswire/ — The Chief Executive Officer of Houston-based Biotechnology Company Stramsen Biotech Inc. Dr. Kefas Mugittu (Ph.D.) has announced 32 Drug…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.